Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA, EMA Confidentiality Agreement Expanding Into "Clusters"

Executive Summary

The "chatter" between reviewers and scientists at FDA and the European Medicines Agency appears to be increasing as the two bodies move toward renewing their confidential information sharing agreement
Advertisement

Related Content

Europe’s EMA And Japan’s PMDA Forge Closer Links On Orphan Drugs
“Breakthrough” Designation Another Harmonization Opportunity, Woodcock Says
FDA/EMA/Industry Action On PML Heralds New Foray Into Collaboration
FDA/EMA/Industry Action On PML Heralds New Foray Into Collaboration
EU Regulator Wants Closer Ties With Health Technology Assessors
Weighing Obesity Risk: FDA, EMEA Use Different Scales For Abbott's Meridia
Adjuvant Vaccines Could Have Helped To Prevent H1N1 Shortfall, Industry Tells Congress
FDA Not More Conservative Than EU, Jenkins Says; Investors Not Convinced

Topics

Advertisement
UsernamePublicRestriction

Register

PS052416

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel